Stromal Cell Coordination of Inflammation and Immunity
Tuesday, June 21, 2022
1:00 PM – 5:00 PM PT
Location: Salons 3/4
Organized By
Description: Fibroblasts are important cells in supporting homeostatic tissue function. In inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and interstitial lung disease, fibroblasts take on different roles 1) as inflammatory cells themselves and 2) in recruiting leukocytes, driving angiogenesis, and enabling chronic inflammation in tissues. Recent advances in single-cell transcriptomics have transformed the ability to examine fibroblast states in inflamed tissues, providing previously underappreciated heterogeneity and disease-associated fibroblast populations. These studies provide new insights into the role of fibroblasts in inflammatory pathology. In addition, new molecular insights into the mechanisms of fibroblast activation reveal novel therapeutic opportunities for the treatment of inflammatory and fibrotic diseases. Speakers will cover novel insights into fibroblast biology and molecular pathways controlling fibroblast pathology. Attendees will acquire critical knowledge related to the role of fibroblasts in inflammatory and fibrotic diseases
Chair: Kevin Wei, MD, PhD Brigham and Women’s Hospital
Program Agenda: 1:00pm - 2:00pm Establishment of a Th2 Cell Niche in Skin Maxime Kinet, MD, PhD University of California, San Francisco
2:00pm - 3:00pm Stromal and Immune Interactions in the Generation and Resolution of Lung Pathology Paul Thomas, PhD St. Jude Children's Research Hospital
3:30pm - 4:15pm Vascular Fibroblasts in Rheumatoid Arthritis Kevin Wei, MD PhD Brigham and Women’s Hospital
4:15pm - 5:00pm Immunofibroblasts in Sjogren’s Syndrome Francesca Barone, PhD University of Birmingham (UK); Candel Therapeutics